Comparison of Antibacterial Activity and Wound Healing in a Superficial Abrasion Mouse Model of Staphylococcus aureus Skin Infection Using Photodynamic Therapy Based on Methylene Blue or Mupirocin or Both
Open Access
- 25 May 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
Abstract
Background: Antibiotic resistance and impaired wound healing are major concerns in S. aureus superficial skin infections, and new therapies are needed. Antimicrobial photodynamic therapy (aPDT) is a new therapeutic approach for infections, but it also improves healing in many wound models.Objective: To compare the antimicrobial activity and the effects on wound healing of aPDT based on Methylene Blue (MB-aPDT) with mupirocin treatment, either alone or in combination, in superficial skin wounds of S. aureus-infected mice. Additionally, to evaluate the clinical, microbiological, and cosmetic effects on wound healing.Materials and Methods: A superficial skin infection model of S. aureus was established in SKH-1 mice. Infected wounds were treated with MB-aPDT, MB-aPDT with a daily topical mupirocin or only with mupirocin. No treatment was carried out in control animals. Daily clinical and microbiological examinations were performed until complete clinical wound healing. Histopathological studies and statistical analysis were performed at the end of the study.Results: MB-aPDT treatment induced the best wound healing compared to mupirocin alone or to mupirocin plus MB-aPDT. Superficial contraction at 24 h and a greater reduction in size at 48 h, quicker detachment of the crust, less scaling, and absence of scars were observed. Histopathological studies correlated with clinical and gross findings. By contrast, mupirocin showed the highest logaritmic reduction of S. aureus.Conclusions: MB-aPDT and mupirocin treatments are effective in a murine superficial skin infection model of S. aureus. One session of MB-aPDT was the best option for clinical wound healing and cosmetic results. The addition of mupirocin to MB-aPDT treatment improved antimicrobial activity; however, it did not enhance wound healing. No synergistic antibacterial effects were detected.Keywords
This publication has 77 references indexed in Scilit:
- Characterization of a Mouse-Adapted Staphylococcus aureus StrainPLOS ONE, 2013
- Antimicrobial Photodynamic Therapy for Methicillin-ResistantStaphylococcus aureusInfectionBioMed Research International, 2013
- A Model for Evaluating Topical Antimicrobial Efficacy against Methicillin-Resistant Staphylococcus aureus Biofilms in Superficial Murine WoundsAntimicrobial Agents and Chemotherapy, 2012
- Surgical Approaches to Create Murine Models of Human Wound HealingBioMed Research International, 2010
- Clearance of experimental cutaneous Staphylococcus aureus infections in miceArchives of Dermatological Research, 2010
- Photodynamic therapy for methicillin‐resistant Staphylococcus aureus infection in a mouse skin abrasion modelLasers in Surgery and Medicine, 2010
- In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agentBMC Microbiology, 2009
- The hairless mouse in skin researchJournal of Dermatological Science, 2009
- Spectrally Resolved Multiphoton Imaging of In Vivo and Excised Mouse Skin TissuesBiophysical Journal, 2007
- Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infectionsJournal of the American Academy of Dermatology, 1989